Development of a novel anti-cancer therapy based on targeting of tumor microvessel endothelial cells
Tsuno, H.; Okaji, Y.; Tanaka, M.; Nagawa, H.; Takahashi, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 527-533
2005
ISSN/ISBN: 0047-1852 PMID: 16201576 Document Number: 592099
Document emailed within 1 workday
Related Documents
Lans, T.E.; Van Horssen, R.; Eggermont, A.M.M.; Ten Hagen, T.L.M. 2004: Involvement of endothelial monocyte activating polypeptide Ii in tumor necrosis factor-alpha-based anti-cancer therapy Anticancer Research 24(4): 2243-2248Vidinský, B.; Gál, P.; Pilátová, M.; Vidová, Z.; Solár, P.; Varinská, L.; Ivanová, L.; Mojžíš, J. 2012: Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation Folia Biologica 58(2): 75-80
Hayashi, S.; Hanamura, T. 2011: Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy Clinical Calcium 21(3): 389-396
Okita, R.; Yamaguchi, Y.; Ohara, M.; Hironaka, K.; Okawaki, M.; Nagamine, I.; Ikeda, T.; Emi, A.; Hihara, J.; Okada, M. 2009: Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer International Journal of Oncology 34(2): 563-572
Dorovini-Zis, K.; Bowman, P.D.; Betz, A.L.; Goldstein, G.W. 1987: Formation of a barrier by brain microvessel endothelial cells in culture Federation Proceedings 46(8): 2521-2522
Del Papa, N.; Meroni, P.L.; Tincani, A.; Harris, E.N.; Pierangeli, S.S.; Barcellini, W.; Borghi, M.O.; Balestrieri, G.; Zanussi, C. 1992: Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells Clinical and Experimental Rheumatology 10(1): 37-42
Stokes, C.L.; Rupnick, M.A.; Williams, S.K.; Lauffenburger, D.A. 1990: Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor Laboratory Investigation; A Journal of Technical Methods and Pathology 63(5): 657-668
Tang, Q.; Ding, Q.; Lin, L.; Zhang, Z.-z.; Dai, Z.; Zhan, J.-b. 2012: Development of antibody drugs targeting against HER2 for cancer therapy Yao Xue Xue Bao 47(10): 1297-1305
Thoenes, L.; Günther, M. 2008: Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy? Current Opinion in Molecular Therapeutics 10(6): 579-590
Yoshioka, Y.; Tsutsumi, Y.; Nakagawa, S.; Mayumi, T. 2004: Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach Current Vascular Pharmacology 2(3): 259-270
Dombrecht, E.J.; Aerts, N.E.; Schuerwegh, A.J.; Hagendorens, M.M.; Ebo, D.G.; Van Offel, J.F.; Bridts, C.H.; Stevens, W.J.; De Clerck, L.S. 2006: Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis Clinical and Experimental Rheumatology 24(1): 31-37
Altorjay, I.; Veréb, Z.; Serfozo, Z.; Bacskai, I.; Bátori, R.; Erdodi, F.; Udvardy, M.; Sipka, S.; Lányi, Á.; Rajnavölgyi, É.; Palatka, K. 2011: Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells International Journal of Immunopathology and Pharmacology 24(2): 323-335
Cunningham, M.P.; Thomas, H.; Marks, C.; Green, M.; Fan, Z.; Modjtahedi, H. 2008: Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells International Journal of Oncology 33(5): 1107-1113
Weninger, W.; Partanen, T.A.; Breiteneder-Geleff, S.; Mayer, C.; Kowalski, H.; Mildner, M.; Pammer, J.; Stürzl, M.; Kerjaschki, D.; Alitalo, K.; Tschachler, E. 1999: Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells Laboratory Investigation; A Journal of Technical Methods and Pathology 79(2): 243-251
Brooks, A.C.; Kanthou, C.; Cook, I.H.; Tozer, G.M.; Barber, P.R.; Vojnovic, B.; Nash, G.B.; Parkins, C.S. 2003: The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro Anticancer Research 23(4): 3199-3206
Berger, G.; Reszka, R.; Pohlen, U.; Jung, M.; Lucas, S.; Buhr, H.J. 1998: Liposome encapsulation of cystostatic drugs and starch microspheres improve tumor targeting in locoregional therapy. An animal experiment study of CC 531 liver tumor Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 693-697
Barshteĭn, I.A.; Persidskiĭ, I.V.; Grutman, M.I. 1990: Interrelationship between the restructuring of liver microvessel endothelium and changes in Kupffer's cells and hepatocytes in the development of gram-negative infection Arkhiv Patologii 52(12): 33-38
Zhou, L.; Feng, Y.-j.; Zhu, M.-w.; Zhang, W.; Jin, H.-m. 2005: Gene transfer of tumor necrosis factor related apoptosis inducing ligand to endothelial progenitor cell for ovarian cancer therapy Zhonghua Fu Chan Ke Za Zhi 40(12): 822-825
Shinomiya, Y.; Harada, M.; Tamada, K.; Kurosawa, S.; Okamoto, T.; Terao, H.; Takenoyama, M.; Ito, O.; Hirashima, C.; Li, T.; Shirakusa, T.; Nomoto, K. 1997: The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12 In Vivo 11(1): 1-8
Geng, M.; Yin, Y.-C.; Cao, Y.-C.; Fu, Z.-J.; Tai, Y.-H. 2008: Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression Zhonghua Wei Chang Wai Ke Za Zhi 11(3): 276-279